RecruitingNot ApplicableNCT05440448

Patch-free Occlusion Therapy


Sponsor

Retina Foundation of the Southwest

Enrollment

68 participants

Start Date

Apr 22, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of the study is to determine whether a patch-free occlusion therapy leads to better visual outcomes in young children with amblyopia than standard-of-care occlusion therapy with an adhesive patch and whether this is associated with better adherence to the treatment.


Eligibility

Min Age: 3 YearsMax Age: 12 Years

Inclusion Criteria6

  • -12 years
  • male and female
  • strabismic, anisometropic, or combined mechanism amblyopia (visual acuity: 0.3-0.8 logMAR)
  • interocular visual acuity difference ≥0.3 logMAR
  • wearing glasses (if needed) for a minimum of 8 weeks with no change in visual acuity at 2 visits ≥4 weeks apart
  • child's ophthalmologist and family willing to forgo standard patching treatment during the study

Exclusion Criteria4

  • Prematurity ≥8 wk
  • coexisting ocular or systemic disease
  • developmental delay
  • myopia > -3.00D

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEPatch-free occlusion therapy

Use of filters in glasses to provide occlusion therapy

DEVICEAdhesive patch

Standard-of-care occlusion therapy with an adhesive patch


Locations(1)

Retina Foundation

Dallas, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05440448


Related Trials